I'm a strong advocate for improving access to experimental cancer therapies, particularly because a drug I got access to pre-approval may have saved my life. Ca

I'm a strong advocate for improving access to experimental cancer therapies, particularly because a drug I got access to pre-approval may have saved my life. Cancer patients should have easier access to novel therapies, and novel therapies should be easier to bring to market. There's a tradeoff between ensuring patient safety on one hand and giving patients access the treatments on the other, and I don't think we're at the right point on that spectrum. On the other hand, I don't particularly trust China to land at my preferred point on that spectrum given a penchant for questionable medical ethics. Ultimately, though, US patients may benefit from Chinese aggressiveness.